NEUMORA THERAPEUTICS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-14: Form 10-Q; Exhibit 10.1; Description Third Amendment to Loan and Security Agreement, dated June 10, 2026, with K2 HealthVentures LLC..
- 2026-03-30: Form 10-K; Exhibit 10.21; Description Second Amendment to Loan and Security Agreement, dated December 10, 2025, with K2 HealthVentures LLC..
- 2025-11-06: Form 10-Q; Exhibit 10.1; Description First Amendment to Loan and Security Agreement, dated November 4, 2025, with K2 HealthVentures LLC.
- 2025-08-06: Form 10-Q; Exhibit 10.2; Description Amended and Restated Non-Employee Director Compensation Program..
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-14 | 10-Q | 10.1 | Third Amendment to Loan and Security Agreement, dated June 10, 2026, with K2 HealthVentures LLC. |
|---|
| 2026-03-30 | 10-K | 10.21 | Second Amendment to Loan and Security Agreement, dated December 10, 2025, with K2 HealthVentures LLC. |
|---|
| 2025-11-06 | 10-Q | 10.1 | First Amendment to Loan and Security Agreement, dated November 4, 2025, with K2 HealthVentures LLC |
|---|
| 2025-08-06 | 10-Q | 10.2 | Amended and Restated Non-Employee Director Compensation Program. |
|---|
| 2025-08-06 | 10-Q | 10.1 | Loan and Security Agreement, dated May 9, 2025, by and among the Registrant, K2 HealthVentures LLC, as lender and administrative agent for the lenders from time to time party thereto, and Ankura Trust Company, LLC, as collateral trustee. |
|---|
| 2025-03-03 | 10-K | 10.20 | Executive Employment Agreement, dated as of August 31, 2023, by and between the Registrant and Robert Lenz, M.D., Ph.D. |
|---|
| 2025-03-03 | 10-K | 10.19 | Executive Employment Agreement, dated as of February 14, 2025, by and between the Registrant and Bill Aurora, Pharm.D. |
|---|
| 2025-03-03 | 10-K | 10.18 | Executive Employment Agreement, dated as of February 14, 2025, by and between the Registrant and Joshua Pinto, Ph.D. |
|---|
| 2025-03-03 | 10-K | 10.17 | Executive Employment Agreement, dated as of February 14, 2025, by and between the Registrant and Michael Milligan. |
|---|
| 2025-03-03 | 10-K | 10.14 | Separation Agreement, dated February 15, 2025, by and between the Registrant and Henry O. Gosebruch. |
|---|
| 2025-03-03 | 10-K | 10.12 | Executive Employment Agreement, effective as of February 14, 2025, by and between the Registrant and Paul L. Berns. |
|---|
| 2024-08-06 | 10-Q | 10.1 | Second Amendment to License Agreement, dated May 17, 2024, by and between the Registrant and Vanderbilt University. |
|---|
| 2024-05-07 | 10-Q | 10.2 | RBNC Therapeutics, Inc. Milestone Carveout Plan |
|---|
| 2024-05-07 | 10-Q | 10.1 | Non-Employee Director Compensation Program. |
|---|
| 2024-03-07 | 10-K | 10.23 | Executive Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Carol Y. Suh. |
|---|
| 2024-03-07 | 10-K | 10.22 | Executive Employment Agreement, dated as of November 13, 2023, by and between the Registrant and Jason Duncan. |
|---|